Active ingredient in magic mushrooms reduces anxiety and depression in cancer patients

December 10, 2015, American College of Neuropsychopharmacology

A single dose of psilocybin, the major hallucinogenic component in magic mushrooms, induces long-lasting decreases in anxiety and depression in patients diagnosed with life-threatening cancer according to a new study presented today at the annual meeting of the American College of Neuropsychopharmacology.

Patients who receive a cancer diagnosis often develop debilitating symptoms of anxiety and depression. Reports from the 1960s and 1970s suggest that hallucinogenic drugs such as LSD may alleviate such symptoms in cancer patients, but the clinical value of for the treatment of mood disturbances in remains unclear. In this new study, Roland Griffiths and colleagues from the Johns Hopkins University School of Medicine investigated the effects of psilocybin on symptoms of anxiety and depression in individuals diagnosed with life-threatening cancer. Five weeks after receiving a dose of psilocybin sufficiently high to induce changes in perception and mystical-type experiences, patients reported significantly lower levels of anxiety and depression compared with patients that received a low dose of the drug. The positive effects on mood persisted in the patients at 6 month follow-up.

The authors suggest that a single dose of may be sufficient to produce enduring decreases in negative mood in with a life-threatening cancer.

Explore further: The potential of psilocybin to alleviate psychological distress in cancer patients is revealed

Related Stories

The potential of psilocybin to alleviate psychological distress in cancer patients is revealed

January 31, 2013
Improvements in the diagnosis and treatment of cancers in recent years have led to a marked increase in patients' physical survival rates. While doctors can treat the physical disease, what is not well understood is how best ...

Could psychedelic drugs be good medicine for some?

September 8, 2015
(HealthDay)—In a carefully controlled setting, psychedelic drugs such as LSD or "magic mushrooms" may benefit patients with hard-to-treat anxiety, addiction or post-traumatic stress disorder (PTSD), new research suggests.

Lower survival rates in women with breast cancer diagnosed with depression

December 1, 2015
Women with breast cancer who subsequently had a recorded diagnosis of depression had a 45% higher risk of death from all causes, according to a study led by King's College London. The researchers suggest this finding could ...

Psilocybin inhibits the processing of negative emotions in the brain

May 7, 2014
Emotions like fear, anger, sadness, and joy enable people to adjust to their environment and react flexibly to stress and strain and are vital for cognitive processes, physiological reactions, and social behaviour. The processing ...

Patients awaiting lung transplant commonly suffer depression-related symptoms

October 19, 2015
Researchers from Mayo Clinic in Rochester, Minnesota, have found patients awaiting lung transplant often suffer from stress, anxiety, or depressive symptoms, and these symptoms are not isolated to patients with pre-existing ...

Recommended for you

Study shows how bias can influence people estimating the ages of other people

October 17, 2018
A trio of researchers from the University of New South Wales and Western Sydney University has discovered some of the factors involved when people make errors in estimating the ages of other people. In their paper published ...

Infants are more likely to learn when with a peer

October 16, 2018
Infants are more likely to learn from on-screen instruction when paired with another infant as opposed to viewing the lesson alone, according to a new study.

Researchers use brain cells in a dish to study genetic origins of schizophrenia

October 16, 2018
A study in Biological Psychiatry has established a new analytical method for investigating the complex genetic origins of mental illnesses using brain cells that are grown in a dish from human embryonic stem cells. Researchers ...

Income and wealth affect the mental health of Australians, study shows

October 16, 2018
Australians who have higher incomes and greater wealth are more likely to experience better mental health throughout their lives, new research led by the Bankwest Curtin Economics Centre has found.

Linguistic red flags from Facebook posts can predict future depression diagnoses

October 15, 2018
In any given year, depression affects more than 6 percent of the adult population in the United States—some 16 million people—but fewer than half receive the treatment they need. What if an algorithm could scan social ...

Early changes to synapse gene regulation may cause Alzheimer's disease

October 15, 2018
Alzheimer's disease (AD) is the most common form of dementia, involving memory loss and a reduction in cognitive abilities. Patients with AD develop multiple abnormal protein structures in their brains that are thought to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.